Antiretroviral therapy coverage (% of people living with HIV)
About this dataset
Columns (4)
Sample rows
| iso3 | year | value | country |
|---|---|---|---|
| AFE | 2024 | 83.9420398567462 | Africa Eastern and Southern |
| AFW | 2024 | 77.1458559536735 | Africa Western and Central |
| ARB | 2024 | 48.5348817779263 | Arab World |
| CSS | 2024 | Caribbean small states | |
| CEB | 2024 | Central Europe and the Baltics | |
| EAR | 2024 | 76.7942816689444 | Early-demographic dividend |
| EAS | 2024 | East Asia & Pacific | |
| EAP | 2024 | East Asia & Pacific (excluding high income) |
A sample of the data. The full table and an interactive map open with a free account.
Related datasets
✦ Suggested by OrionAIPercentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).
Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.
Children living with HIV refers to the number of children ages 0-14 who are infected with HIV.
Number of new HIV infections among uninfected populations ages 15-49 expressed per 1,000 uninfected population in the year before the period.
Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.
Number of adults (ages 15-49) newly infected with HIV.
Indexed by OrionGIS from World Bank Open Data (Indicators API v2). Data is loaded from the publisher's own server when you use it. Permanent link